BSC creates a computational method that reveals previously hidden connections between diseases
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Jan-2026 04:11 ET (2-Jan-2026 09:11 GMT/UTC)
Researchers observed positive interactions, in which one disease favours the onset of another, such as between asthma and Parkinson's disease; and negative interactions, in which some groups of patients with one disease may be protected from developing others, such as between cancer and Huntington's disease.
BSC has developed a publicly accessible interactive platform that visualises the network of connections between diseases and proposes previously undescribed interactions, such as those between Down syndrome and lupus, thus opening the door to new therapeutic strategies.BUFFALO, NY — September 2, 2025 — A new research paper featured on the cover of Volume 17, Issue 8 of Aging (Aging-US) was published on July 30, 2025, titled “Exosomes released from senescent cells and circulatory exosomes isolated from human plasma reveal aging-associated proteomic and lipid signatures.”
The Icahn School of Medicine at Mount Sinai will award its 2025 Yergin-New International Prize for Biomedical Research to Michael J. Welsh, MD, of the University of Iowa for his pioneering work in cystic fibrosis (CF), which has significantly advanced understanding and treatment of this chronic, inherited lung disease with an onset in children. This prize, formerly known as the Maria I. New International Prize for Biomedical Research, honors medical innovators who exemplify the values and dedication of the late Maria I. New, MD, a world-renowned researcher in pediatric genetic disorders who maintained special focus on endocrinology throughout her six-decade career. Dr. Welsh will receive a $50,000 award and will deliver the Maria I. New Distinguished Lecture during a ceremony to be held at Mount Sinai in New York City.
The International Society for Autism Research (INSAR) is pleased to announce the appointment of Dr. Diana Schendel of Drexel University as the new Editor-in-Chief of Autism Research, the society’s flagship scientific journal. Dr. Schendel will assume the role beginning January 1, 2026.